• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左炔诺孕酮宫内节育系统(LNG-IUS)的用户满意度:一项国际调查的数据

User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.

作者信息

Römer Thomas, Linsberger Doris

机构信息

Evangelisches Krankenhaus Köln-Weyertal GmbH, Köln, Germany.

出版信息

Eur J Contracept Reprod Health Care. 2009 Dec;14(6):391-8. doi: 10.3109/13625180903203154.

DOI:10.3109/13625180903203154
PMID:19929641
Abstract

OBJECTIVES

To identify the characteristics of an international population of women using the levonorgestrel-releasing intrauterine system (LNG-IUS) and their experiences with this contraceptive.

METHODS

Women who had used the LNG-IUS for six months or more completed a standardised questionnaire on reasons for use, user satisfaction and other aspects.

RESULTS

A total of 8680 questionnaires were completed by survey participants in 18 countries across Europe and the Near East. The average woman using the LNG-IUS was 38 years old, was married or lived with her partner, and had two children. Overall, 95% of patients were satisfied with the LNG-IUS; the percentage rose to 99% among those using their second LNG-IUS. Reasons mentioned for using the LNG-IUS included the need for contraception (68%), its high efficacy (59%) and the shorter/lighter menstrual bleeding (55%). Of the women with prior bleeding problems, 93% reported an improvement in their symptoms with the LNG-IUS. Participants also rated the reliability, tolerability and convenience of the method highly.

CONCLUSIONS

This survey provides insight into the profiles of LNG-IUS users. High levels of satisfaction with this method of contraception were reported by both first and second-time users. Our data suggest that the LNG-IUS is well accepted and that it provides considerable benefits beyond contraception alone.

摘要

目的

确定使用左炔诺孕酮宫内节育系统(LNG-IUS)的国际女性群体的特征及其使用这种避孕方法的体验。

方法

使用LNG-IUS六个月或更长时间的女性完成了一份关于使用原因、用户满意度及其他方面的标准化问卷。

结果

欧洲和近东18个国家的调查参与者共完成了8680份问卷。使用LNG-IUS的女性平均年龄为38岁,已婚或与伴侣同居,育有两个孩子。总体而言,95%的患者对LNG-IUS满意;在使用第二个LNG-IUS的患者中,这一比例升至99%。提及使用LNG-IUS的原因包括需要避孕(68%)、其高效性(59%)以及月经出血减少/变轻(55%)。在有既往出血问题的女性中,93%报告使用LNG-IUS后症状有所改善。参与者对该方法的可靠性、耐受性和便利性也给予了高度评价。

结论

这项调查深入了解了LNG-IUS使用者的情况。首次和再次使用者对这种避孕方法的满意度都很高。我们的数据表明,LNG-IUS被广泛接受,并且它不仅在避孕方面,还能带来相当多的益处。

相似文献

1
User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.左炔诺孕酮宫内节育系统(LNG-IUS)的用户满意度:一项国际调查的数据
Eur J Contracept Reprod Health Care. 2009 Dec;14(6):391-8. doi: 10.3109/13625180903203154.
2
The Femilis LNG-IUS: contraceptive performance-an interim analysis.费米利斯左炔诺孕酮宫内缓释系统:避孕效果——一项中期分析。
Eur J Contracept Reprod Health Care. 2009 Apr;14(2):103-10. doi: 10.1080/13625180802706059.
3
Subject and clinician experience with the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统的受试者及临床医生经验
Contraception. 2008 Jan;77(1):22-9. doi: 10.1016/j.contraception.2007.09.006. Epub 2007 Nov 26.
4
Levonorgestrel-releasing intrauterine system: why do some women dislike it?左炔诺孕酮宫内节育系统:为何有些女性不喜欢它?
Gynecol Endocrinol. 2008 Dec;24(12):686-90. doi: 10.1080/09513590802444167.
5
Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.曼月乐(左炔诺孕酮宫内节育系统):一种成功的新型避孕药物递送选择。
Adv Drug Deliv Rev. 2009 Aug 10;61(10):808-12. doi: 10.1016/j.addr.2009.04.022. Epub 2009 May 13.
6
Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.左炔诺孕酮宫内节育系统在有止血障碍女性中的应用。
Fertil Steril. 2008 Sep;90(3):673-7. doi: 10.1016/j.fertnstert.2007.07.1315. Epub 2007 Nov 14.
7
Use of the levonorgestrel releasing-intrauterine system in nulliparous women--a non-interventional study in Sweden.在未生育女性中使用左炔诺孕酮宫内节育系统——瑞典的一项非干预性研究。
Eur J Contracept Reprod Health Care. 2011 Apr;16(2):126-34. doi: 10.3109/13625187.2011.558222.
8
Sixty thousand woman-years of experience on the levonorgestrel intrauterine system: an epidemiological survey in Finland.左炔诺孕酮宫内节育系统的60000人年使用经验:芬兰的一项流行病学调查。
Eur J Contracept Reprod Health Care. 2001 Jan;6 Suppl 1:23-6.
9
Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.新型含左炔诺孕酮T形宫内节育系统的置入便利性、避孕效果及安全性
Contraception. 2005 Jun;71(6):465-9. doi: 10.1016/j.contraception.2004.12.021.
10
Selection and performance of the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统的选择与性能
Acta Obstet Gynecol Scand Suppl. 1997;164:69-74.

引用本文的文献

1
Pain experiences during intrauterine device procedures: a thematic analysis of tweets.宫内节育器放置术中的疼痛体验:推特主题分析。
BMJ Sex Reprod Health. 2024 Oct 15;50(4):271-277. doi: 10.1136/bmjsrh-2023-202011.
2
The use of LNG-IUS-19.5 mg in daily gynecological routine practice in Germany: data from the Kyleena™ Satisfaction Study (KYSS).德国日常妇科实践中使用19.5毫克左炔诺孕酮宫内缓释系统:来自凯琳娜™满意度研究(KYSS)的数据。
Arch Gynecol Obstet. 2024 May;309(5):2021-2030. doi: 10.1007/s00404-024-07421-5. Epub 2024 Feb 29.
3
Hormonal intrauterine device in women with renal transplantation: a prospective observational study.
激素宫内节育器在肾移植女性中的应用:一项前瞻性观察研究。
Rev Assoc Med Bras (1992). 2023 Sep 18;69(10):e20230352. doi: 10.1590/1806-9282.20230352. eCollection 2023.
4
Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India.在印度基层医疗环境中,左炔诺孕酮宫内节育器作为长效可逆避孕方法的可行性和可接受性的观察性研究。
Contracept X. 2022 Jun 30;4:100079. doi: 10.1016/j.conx.2022.100079. eCollection 2022.
5
Introducing the hormonal Intrauterine Device in Madagascar, Nigeria, and Zambia: results from a pilot study.在马达加斯加、尼日利亚和赞比亚引入激素宫内节育器:一项试点研究的结果。
Reprod Health. 2022 Jan 6;19(1):4. doi: 10.1186/s12978-021-01300-x.
6
Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications.新型聚合物载体系统用于子宫内递送电生理用于癌症治疗。
J Control Release. 2021 Nov 10;339:521-530. doi: 10.1016/j.jconrel.2021.10.008. Epub 2021 Oct 12.
7
Comparing options for females seeking permanent contraception in high resource countries: a systematic review.高资源国家中寻求永久避孕的女性的选择比较:一项系统综述
Reprod Health. 2021 Jul 20;18(1):154. doi: 10.1186/s12978-021-01201-z.
8
Modern contraceptive availability and stockouts: a multi-country analysis of trends in supply and consumption.现代避孕用品的可及性与缺货情况:供应与消费趋势的多国分析
Health Policy Plan. 2021 Apr 21;36(3):273-287. doi: 10.1093/heapol/czaa197.
9
Levonorgestrel-Releasing Intrauterine System as a Contraceptive Method in Nulliparous Women: A Systematic Review.左炔诺孕酮宫内节育系统作为未生育女性的避孕方法:一项系统评价。
J Clin Med. 2020 Jul 3;9(7):2101. doi: 10.3390/jcm9072101.
10
Comparative satisfaction of receiving medical abortion service from nurses and auxiliary nurse-midwives or doctors in Nepal: results of a randomized trial.尼泊尔的护士和助理护士助产士与医生提供药物流产服务的满意度比较:一项随机试验的结果。
Reprod Health. 2017 Dec 16;14(1):176. doi: 10.1186/s12978-017-0438-7.